Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology : Hopes and DisappointmentsBRANDES, Alba A; FRANCESCHI, Enrico; TOSONI, Alicia et al.Clinical cancer research. 2008, Vol 14, Num 4, pp 957-960, issn 1078-0432, 4 p.Article

MGMT promoter methylation in malignant gliomasRIEMENSCHNEIDER, Markus J; HEGI, Monika E; REIFENBERGER, Guido et al.Targeted oncology. 2010, Vol 5, Num 3, pp 161-165, issn 1776-2596, 5 p.Article

Epigenetic Deregulation of DNA Repair and Its Potential for TherapyHEGI, Monika E; SCIUSCIO, Davide; MURAT, Anastasia et al.Clinical cancer research (Print). 2009, Vol 15, Num 16, pp 5026-5031, issn 1078-0432, 6 p.Article

Endothelin receptor type B counteracts tenascin-C-induced endothelin receptor type A-dependent focal adhesion and actin stress fiber disorganizationLANGE, Katrin; KAMMERER, Martial; OREND, Gertraud et al.Cancer research (Baltimore). 2007, Vol 67, Num 13, pp 6163-6173, issn 0008-5472, 11 p.Article

Stem Cell-Related Self-Renewal Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in GlioblastomaMURAT, Anastasia; MIGLIAVACCA, Eugenia; HAINFELLNER, Johannes A et al.Journal of clinical oncology. 2008, Vol 26, Num 18, pp 3015-3024, issn 0732-183X, 10 p.Article

Prognostic factors for low-grade gliomasSTUPP, Roger; JANZER, Robert C; HEGI, Monika E et al.Seminars in oncology. 2003, Vol 30, Num 6, pp 23-28, issn 0093-7754, 6 p., SUP19Conference Paper

Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1ALBERTONI, Michele; SHAW, Phillip H; VAN MEIR, Erwin G et al.Oncogene (Basingstoke). 2002, Vol 21, Num 27, pp 4212-4219, issn 0950-9232, 8 p.Article

Presence of Alternative Lengthening of Telomeres Mechanism in Patients With Glioblastoma Identifies a Less Aggressive Tumor Type With Longer SurvivalMCDONALD, Kerrie L; MCDONNELL, Julie; ROBINSON, Bruce G et al.Journal of neuropathology and experimental neurology. 2010, Vol 69, Num 7, pp 729-736, issn 0022-3069, 8 p.Article

Tenascin-C Is a Novel RBPJκ-Induced Target Gene for Notch Signaling in GliomasSIVASANKARAN, Balasubramanian; DEGEN, Martin; MISEREZ, André R et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 2, pp 458-465, issn 0008-5472, 8 p.Article

Differential gene expression analysis reveals activation of growth promoting signaling pathways by tenascin-CRUIZ, Christian; HUANG, Wentao; HEGI, Monika E et al.Cancer research (Baltimore). 2004, Vol 64, Num 20, pp 7377-7385, issn 0008-5472, 9 p.Article

Chemoradiotherapy in malignant glioma : Standard of care and future directionsSTUPP, Roger; HEGI, Monika E; GILBERT, Mark R et al.Journal of clinical oncology. 2007, Vol 25, Num 26, pp 4127-4136, issn 0732-183X, 10 p.Article

A Safety Run-In and Randomized Phase 2 Study of Cilengitide Combined With Chemoradiation for Newly Diagnosed Glioblastoma (NABTT 0306)NABORS, L. Burt; MIKKELSEN, Thomas; FISHER, Joy D et al.Cancer. 2012, Vol 118, Num 22, pp 5601-5607, issn 0008-543X, 7 p.Article

MGMT gene silencing and benefit from temozolomide in glioblastomaHEGI, Monika E; DISERENS, Annie-Claire; BROMBERG, Jacoline E. C et al.The New England journal of medicine. 2005, Vol 352, Num 10, pp 997-1003, issn 0028-4793, 7 p.Article

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomideHEGI, Monika E; DISERENS, Annie-Claire; GODARD, Sophie et al.Clinical cancer research. 2004, Vol 10, Num 6, pp 1871-1874, issn 1078-0432, 4 p.Article

Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutantKLEIN, Michael A; RÜEDI, Daniela; NOZAKI, Michimasa et al.Oncogene (Basingstoke). 2000, Vol 19, Num 47, pp 5329-5337, issn 0950-9232Article